maternity

Hemolysis and HELLP Syndrome

  • Definition of Hemolysis

    • Hemolysis refers to the rapid breakdown of red blood cells (RBCs) in the body.

  • Dysfunction Indicated by Hemolysis

    • A key organ associated with this process is the liver, which is described as a “beast” and is highly vascular. It's responsible for producing clotting factors, and when it fails, it leads to increased hemolysis of RBCs.

Clinical Presentation of Hemolysis

  • When a person is experiencing hemolysis, they may present with:

    • Petechiae: Small, pinpoint red spots on the skin resulting from bleeding.

    • Petechiae is a symptom of the failure of clotting due to low platelet levels.

    • Jaundice: Yellowing of the skin and the eyes is due to elevated levels of bilirubin from the breakdown of RBCs.

    • This condition can also lead to clay-colored stools and coffee-colored urine (often described metaphorically as “Coca-Cola urine”).

HELLP Syndrome Description

  • Definition

    • HELLP syndrome is an acronym for:

    • Hemolysis

    • Elevated Liver enzymes (specifically AST and ALT)

    • Low Platelets

    • Symptoms include: petechiae, ecchymosis, jaundice, clay-colored stool, and coffee-colored urine.

Breakdown of HELLP Components

  • Hemolysis:

    • Defined as the rapid breakdown of red blood cells.

    • This process leads to an increase in bilirubin levels, hence causing jaundice.

  • Elevated Liver Enzymes:

    • Liver enzymes, particularly AST (Aspartate Aminotransferase) and ALT (Alanine Aminotransferase), are markers of liver dysfunction or damage.

  • Low Platelets:

    • A state of thrombocytopenia which indicates poor clotting ability and thus a higher tendency for bleeding.

    • Resultant petechiae and symptoms of bleeding do not manifest as clear bleeding from the mucous membranes but appear as skin discolorations.

Clinical Presentation Related to HELLP Syndrome

  • Symptoms include:

    • Blurred vision, epigastric pain, significant swelling, particularly above the waist.

Connection to Preeclampsia

  • The evolution from mild preeclampsia to HELLP syndrome is marked by the worsening of symptoms when hypertension and protein levels increase in urine, indicating severe preeclampsia.

    • A threshold of protein in urine for mild preeclampsia is 1+ or 2+, while severe preeclampsia requires a reading of 3+ or 4+.

Risk of Complications

  • Severe Happenings:

    • If HELLP syndrome progresses without intervention, it may lead to Disseminated Intravascular Coagulation (DIC), characterized by simultaneous clotting and bleeding due to underlying coagulation issues, often leading to severe morbidity or mortality.

  • DIC Implications:

    • It is often described as “death syndrome” due to the body’s separate processes of clotting and bleeding that exacerbate each other, complicating treatment.

Initial Management

  • Initial Signs:

    • If a patient presents with hypertension (e.g., 140/90), blurred vision, headache, and epigastric pain, close monitoring and intervention are required.

    • The most pressing need is usually fluid and pharmacological intervention, especially for hypertension.

Urgent Medical Treatment

  • Medications Needed:

    • Antihypertensive medication is essential when blood pressure rises significantly (e.g., 160/110), with careful monitoring to prevent seizures (e.g., using magnesium sulfate).

    • Monitoring should include checking for reflexes and signs of impending seizures, managing potential toxicity from magnesium by having calcium gluconate readily available.

Monitoring Protocols

  • Continuous assessment of vital signs should be conducted every 15 minutes to detect signs of magnesium toxicity or severe hypertension.

  • Signs of potential side effects of magnesium include respiratory depression and changes in reflex activity.

Veal Chop and Fetal Heart Rate Monitoring

VEAL CHOP Breakdown

  • VEAL CHOP is used to interpret fetal heart rate patterns in relation to contractions:

    • V: Variable decelerations

    • Cause: Cord compression.

    • Management includes changing maternal position.

    • E: Early decelerations

    • Cause: Head compression.

    • Not a significant concern if normal homeostasis is achieved after a contraction.

    • A: Accelerations O

    • Sign of fetal well-being; no immediate intervention required.

    • L: Late decelerations

    • Cause: Placenta Uteroplacental insufficiency; requires urgent intervention (e.g., reposition, increase oxygen supply, notify MD).

Managing Late Decelerations

  • Management strategy includes:

    • Reposition